S. 1157Passed one chamberHealth care
Bill orders federal review of lung cancer research gaps for women
Data as of July 14, 2026
The bill requires HHS to study lung cancer research gaps affecting women and underserved groups, with a report due to Congress in two years.30-second read · 4 questions answered below
Decoded
What does this do?
This bill directs HHS, working with the Defense Department and Veterans Affairs, to review how lung cancer research and prevention efforts address women and underserved groups. The review covers causes, early detection technology, a national screening strategy, and a public awareness campaign, with findings reported to Congress within two years.
Who does it affect?
Women, underserved communities with limited healthcare access, lung cancer researchers, and government health agencies are most affected.
Why does it matter?
The review could shape future federal screening, prevention, and education programs, though it creates no new programs immediately.
Where does it stand?
- Introduced
- Senate committee
- Senate vote
- House — You are here
- President's desk
Right now: it passed the Senate and now goes to the House. If the House changes it, it goes back to the Senate before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
Women and Lung Cancer Research and Preventive Services Act of 2025
- Introduced:
- March 26, 2025
- Latest action:
- June 9, 2026
Held at the desk.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.